NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

NZ sharemarket up as Sanford rides the wave
Markets Market Close

NZ sharemarket up as Sanford rides the wave

Sanford’s result was its best in a decade.

Tom Raynel 15 May 2025
Why Xero is loyal to the ASX
Markets

Why Xero is loyal to the ASX

Cloud accounting firm 'happy to show up differently', CEO says.

NZX listing costs to fall
Markets

NZX listing costs to fall

The cost of providing PFI ranges from around $150,000 to $500,000, says NZX. 

Rebecca Howard 15 May 2025
Briscoe Group has plans for smaller ‘Metro stores’
Retail

Briscoe Group has plans for smaller ‘Metro stores’

There could be an opportunity for up to 15 new stores, COO Andrew Scott says.

Gregor Thompson 15 May 2025